Zuo‐Feng Zhang

机构：University of California, Los Angeles · ORCID：0000-0002-4669-3995

发表论文 904 篇 · 总被引 38559 次 · h-index 108

代表论文

LBA2 Perioperative (periop) enfortumab vedotin (EV) plus pembrolizumab (pembro) in participants (pts) with muscle-invasive bladder cancer (MIBC) who are cisplatin-ineligible: The phase III KEYNOTE-905 study (2025 · Annals of Oncology · 被引 43)
Coffee and tea consumption and the risk of head and neck cancer: An updated pooled analysis in the International Head and Neck Cancer Epidemiology Consortium (2024 · Cancer · 被引 11)
Dual advantages of SN38 prodrug nanoassemblies overcome defects of irinotecan and SN38: enhanced stability and activatability (2025 · Science China Chemistry · 被引 10)
An Anti–saliva contamination Bonding Strategy Based on Polycation Assembly (2025 · Journal of Dental Research · 被引 7)
A High Temperature Resistant and Sewable Aromatic Multiscale Fiber for Rapid Identification in Fire Rescue (2025 · Nano Letters · 被引 6)
The association between insulin resistance-related markers and ASCVD with hyperuricemia: results from the 2005 to 2018 National Health and Nutrition Examination Survey (2025 · Frontiers in Cardiovascular Medicine · 被引 5)